These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3699321)

  • 21. The long-acting cholinesterase inhibitor heptyl-physostigmine attenuates the scopolamine-induced learning impairment of rats in a 14-unit T-maze.
    Iijima S; Greig NH; Garofalo P; Spangler EL; Heller B; Brossi A; Ingram DK
    Neurosci Lett; 1992 Sep; 144(1-2):79-83. PubMed ID: 1436716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determination of physostigmine in plasma and brain by HPLC.
    Somani SM; Khalique A
    J Anal Toxicol; 1985; 9(2):71-5. PubMed ID: 3921763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of physostigmine after intravenous, intramuscular and subcutaneous administration in surgical patients.
    Hartvig P; Wiklund L; Lindström B
    Acta Anaesthesiol Scand; 1986 Feb; 30(2):177-82. PubMed ID: 3705906
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of a new radiometric high-performance liquid chromatographic assay to define physostigmine pharmacokinetics in guinea pigs.
    Lukey BJ; Marlow DD; Clark CR; McCluskey MP; Lieske CN
    J Chromatogr; 1989 Aug; 493(1):117-24. PubMed ID: 2778001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of physostigmine in plasma by high-performance liquid chromatography and fluorescence detection.
    Elsayed NM; Ryabik JR; Ferraris S; Wheeler CR; Korte DW
    Anal Biochem; 1989 Feb; 177(1):207-11. PubMed ID: 2742149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endurance training changes central and peripheral responses to physostigmine.
    Somani SM; Dube SN
    Pharmacol Biochem Behav; 1992 Apr; 41(4):773-81. PubMed ID: 1594645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of pharmacokinetics of M1, M2, M3, and M4 after intravenous administration of DA-125 or ME2303 to mice and rats. New adriamycin analogues containing fluorine.
    Yoon EJ; Lee WI; Shim HJ; Lee SD; Kim WB; Yang J; Lee MG
    Biopharm Drug Dispos; 1996 Jul; 17(5):373-420. PubMed ID: 8830976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simple liquid chromatographic method for the determination of physostigmine and its metabolite eseroline in rat plasma: application to a pharmacokinetic study.
    Zhao B; Moochhala SM; Chaw CS; Yang YY
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Feb; 784(2):323-9. PubMed ID: 12505780
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics, tissue distribution, and metabolism of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (NSC 707545) in CD2F1 mice and Fischer 344 rats.
    Egorin MJ; Lagattuta TF; Hamburger DR; Covey JM; White KD; Musser SM; Eiseman JL
    Cancer Chemother Pharmacol; 2002 Jan; 49(1):7-19. PubMed ID: 11855755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extraction of physostigmine from biologic fluids and analysis by liquid chromatography with electrochemical detection.
    Lawrence GD; Yatim N
    J Pharmacol Methods; 1990 Sep; 24(2):137-43. PubMed ID: 2232817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 2nd communication: distribution and transfer into the fetus and milk after a single intravenous administration and pharmacokinetics and enzyme induction after repeated intravenous administration to rats.
    Sugimoto T; Hayashi T; Okita A; Morino A
    Arzneimittelforschung; 1996 Feb; 46(2):114-27. PubMed ID: 8720299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics and tissue distribution of halofuginone (NSC 713205) in CD2F1 mice and Fischer 344 rats.
    Stecklair KP; Hamburger DR; Egorin MJ; Parise RA; Covey JM; Eiseman JL
    Cancer Chemother Pharmacol; 2001 Nov; 48(5):375-82. PubMed ID: 11761455
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disposition and metabolism of [14C]-haloperidol in rats.
    Miyazaki H; Matsunaga Y; Nambu K; Oh-e Y; Yoshida K; Hashimoto M
    Arzneimittelforschung; 1986 Mar; 36(3):443-52. PubMed ID: 3707663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo imaging of human cerebral acetylcholinesterase.
    Pappata S; Tavitian B; Traykov L; Jobert A; Dalger A; Mangin JF; Crouzel C; DiGiamberardino L
    J Neurochem; 1996 Aug; 67(2):876-9. PubMed ID: 8764619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of subacute administration of physostigmine on blood acetylcholinesterase activity, motor performance, and soman intoxication.
    Harris LW; Anderson DR; Lennox WJ; Solana RP
    Toxicol Appl Pharmacol; 1989 Feb; 97(2):267-71. PubMed ID: 2922758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enantiomer (+)physostigmine prevents organophosphate-induced subjunctional damage at the neuromuscular synapse by a mechanism not related to cholinesterase carbamylation.
    Kawabuchi M; Boyne AF; Deshpande SS; Cintra WM; Brossi A; Albuquerque EX
    Synapse; 1988; 2(2):139-47. PubMed ID: 3420535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Facile hydrolysis of mebeverine in vitro and in vivo: negligible circulating concentrations of the drug after oral administration.
    Dickinson RG; Baker PV; Franklin ME; Hooper WD
    J Pharm Sci; 1991 Oct; 80(10):952-7. PubMed ID: 1784004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of SCE-1141, a stereoisomer of cefmenoxime, in rats.
    Kita Y; Itakura K; Tsuchiya K; Imada A
    J Antimicrob Chemother; 1986 Feb; 17(2):205-13. PubMed ID: 3457784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics and tissue distribution of ketanserin in rat, rabbit and dog.
    Michiels M; Monbaliu J; Meuldermans W; Hendriks R; Geerts R; Woestenborghs R; Heykants J
    Arzneimittelforschung; 1988 Jun; 38(6):775-84. PubMed ID: 3178917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intracerebroventricular physostigmine facilitates heat loss mechanisms in running rats.
    Rodrigues AG; Lima NR; Coimbra CC; Marubayashi U
    J Appl Physiol (1985); 2004 Jul; 97(1):333-8. PubMed ID: 15033963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.